Study of a new test for flu, RSV, and COVID-19 in people with symptoms
Part of Infections, Lungs & breathing clinical trials.
This trial evaluates a new test that can detect flu A/B, RSV, and COVID-19 from a single nose swab. It is for people who are currently sick with respiratory symptoms and are either hospitalized, in the ER, visiting a clinic, or living in a long-term care facility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a nose or throat swab already collected in a specific transport liquid.
- You are currently in the hospital, emergency room, outpatient clinic, or a long-term care facility.
- You have active symptoms of a respiratory infection (like cough, fever, or sore throat).
- The leftover swab sample must be at least half a milliliter (about the size of a pea) for some types, or more for others.
- The sample must have been kept in the refrigerator (not frozen) for no more than 3 days before testing, or frozen very cold if delayed.
- The sample cannot have been frozen and thawed more than two times.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a single rapid test can correctly identify flu, COVID-19, and RSV from one nose swab. If you or your child have symptoms like fever, cough, or runny nose, this test might give quick answers.
This study evaluates a home test kit that detects respiratory infections like the flu, RSV, and COVID-19 from a simple nose swab. It helps see if the test works well when used outside a clinic.
This study tests an at-home rapid test that checks for flu A, flu B, and COVID-19 all at once. If you have symptoms now, this trial helps see if the test is accurate enough for home use.
This study tests a quick nasal swab test that can tell if you have COVID-19, flu A, or flu B. It helps see if the test works well in the Southern Hemisphere, which may help doctors diagnose and treat respiratory infections faster.
This trial uses a rapid test in the emergency department to quickly identify the exact cause of your respiratory infection, such as the flu or other viruses. This may help doctors choose the right treatment faster, potentially reducing hospital stays and improving outcomes.
This study is testing a new, easy-to-use COVID-19 test called the Metrix COVID-19 Test. If you have a fever or other cold or flu-like symptoms today, you may help confirm if this test works well.
Hear when a new Influenza B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.